Development of Device Therapy for Ventricular Arrhythmias

Holley, LK

Development of Device Therapy for Ventricular Arrhythmias

Holley, LK

Permalink

Publication Type:: Journal Article
Citation:: Heart Lung and Circulation, 2007, 16 (3), pp. 162 - 169
Issue Date:: 2007-06-01

Closed Access

	Filename	Description	Size
	2007002460.pdf		167.15 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Holley, LK	en_US
dc.date.issued	2007-06-01	en_US
dc.identifier.citation	Heart Lung and Circulation, 2007, 16 (3), pp. 162 - 169	en_US
dc.identifier.issn	1443-9506	en_US
dc.identifier.uri	http://hdl.handle.net/10453/4428
dc.description.abstract	The past 25 years have seen the implantable cardioverter defibrillator emerge as the treatment of choice for ventricular arrhythmias with reduction in size but increased therapeutic options. Understanding the complex mechanisms of ventricular arrhythmias and defibrillation in normal and diseased hearts has been the focus of many research teams including that of John Uther at the Westmead Hospital Department of Cardiology. Marked improvements in capacitor and battery technologies, arrhythmia discrimination, pacing algorithms, shock waveforms and monitoring capabilities enable wider use and patient acceptance. Emergence of cardiac resynchronisation therapy and the implantable defibrillator for treatment of chronic heart failure is not only giving quality of life and extended survival for heart failure patients but has also cast new light on the evolution of heart failure. © 2007 Australasian Society of Cardiac and Thoracic Surgeons and the Cardiac Society of Australia and New Zealand.	en_US
dc.relation.ispartof	Heart Lung and Circulation	en_US
dc.relation.isbasedon	10.1016/j.hlc.2007.02.104	en_US
dc.subject.classification	Cardiovascular System & Hematology	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Ventricular Dysfunction, Left	en_US
dc.subject.mesh	Cardiac Pacing, Artificial	en_US
dc.subject.mesh	Electric Countershock	en_US
dc.subject.mesh	Equipment Design	en_US
dc.subject.mesh	Defibrillators, Implantable	en_US
dc.subject.mesh	Pacemaker, Artificial	en_US
dc.subject.mesh	Biomedical Engineering	en_US
dc.subject.mesh	Biomedical Research	en_US
dc.subject.mesh	History, 20th Century	en_US
dc.subject.mesh	History, 21st Century	en_US
dc.subject.mesh	Computer Simulation	en_US
dc.subject.mesh	Arrhythmias, Cardiac	en_US
dc.title	Development of Device Therapy for Ventricular Arrhythmias	en_US
dc.type	Journal Article
utslib.citation.volume	3	en_US
utslib.citation.volume	16	en_US
utslib.for	110299 Cardiorespiratory Medicine and Haematology not elsewhere classified	en_US
utslib.for	1102 Cardiorespiratory Medicine and Haematology	en_US
utslib.for	1117 Public Health and Health Services	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
utslib.copyright.status	closed_access
pubs.issue	3	en_US
pubs.publication-status	Published	en_US
pubs.volume	16	en_US

Abstract:

The past 25 years have seen the implantable cardioverter defibrillator emerge as the treatment of choice for ventricular arrhythmias with reduction in size but increased therapeutic options. Understanding the complex mechanisms of ventricular arrhythmias and defibrillation in normal and diseased hearts has been the focus of many research teams including that of John Uther at the Westmead Hospital Department of Cardiology. Marked improvements in capacitor and battery technologies, arrhythmia discrimination, pacing algorithms, shock waveforms and monitoring capabilities enable wider use and patient acceptance. Emergence of cardiac resynchronisation therapy and the implantable defibrillator for treatment of chronic heart failure is not only giving quality of life and extended survival for heart failure patients but has also cast new light on the evolution of heart failure. © 2007 Australasian Society of Cardiac and Thoracic Surgeons and the Cardiac Society of Australia and New Zealand.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/4428